Roblox stock tumbles nearly 10% premarket as age-check rollout comes under the microscope

Roblox stock tumbles nearly 10% premarket as age-check rollout comes under the microscope

New York, Jan 21, 2026, 05:29 (ET) — Premarket

  • Roblox shares dipped roughly 10% before the U.S. market opened
  • An analyst note pointed out there’s no early “material” impact on spending from Roblox’s new age verification for chat
  • Investors are eyeing Roblox’s Feb. 5 earnings for a clearer picture of demand in 2026

Roblox Corp shares slipped 9.7% to $78.84 in premarket trading Wednesday.

The shift came after a tough session for growth stocks Tuesday, as fresh trade and geopolitical concerns rattled risk appetite. The Nasdaq dropped 2.4%, and the S&P 500 lost 2.1%, according to the Wall Street Journal. (Wall Street Journal)

Roblox is in focus because investors want to see if the company’s new age-check for chat might slow user engagement or spending. On Tuesday, Oppenheimer kept its Outperform rating and $150 price target, noting that initial checks on top Roblox games found no “material” negative effects yet. Still, they warned the sample size is small and the rollout is fresh. (Investing.com)

Roblox has implemented a global update this month, mandating that users pass an age verification before they can use chat features. The platform now sorts users into age categories to restrict interactions between minors and adults. “By building proactive, age-based barriers, we can empower users to create and connect in ways that are both safe and appropriate,” said Chief Safety Officer Matt Kaufman in a company statement. (Roblox Investor Relations)

Investors are closely monitoring bookings—a crucial Roblox metric that measures demand for its virtual currency and related spending before it hits the revenue line—for signs of increased friction. Since chat plays a central role in many experiences, changes in user interaction could directly impact both time spent and purchase behavior.

Roblox faces a tough balancing act: it must assure regulators and parents it’s boosting safety, yet also convince investors it can maintain growth. The wider tech selloff only makes the company’s next move more critical.

That early read might still change. If more users put off or skip the age check, or if creators spot less social activity in games reliant on chat to keep players, spending could dip fast — and investors have shown they’re swift to punish growth stocks when the numbers get shaky.

Roblox announced it will release its fourth-quarter and full-year 2025 earnings after the market close on Feb. 5. A conference call is set for 4:30 p.m. ET. (Roblox Investor Relations)

Traders are zeroing in on that report as the next major milestone: updates on bookings and user engagement, plus any initial clues on whether the chat age-check rollout is hurting growth, making no difference, or something management can spin as a long-term win.

Stock Market Today

  • 908 Devices Shares Surge 19.2% on Strong Q4 Preview: Sustainability Questioned
    January 21, 2026, 7:25 AM EST. 908 Devices (MASS) shares jumped 19.2% to $6.52 on heavy volume following a preliminary fourth-quarter revenue report showing 20% growth to $17.2 million. Gains stemmed from strong U.S. state and local sales, rising international adoption, and federal contracts. The company posted positive adjusted EBITDA in Q4 but is still expected to report a quarterly loss of $0.06 per share, albeit an 81.3% improvement year-over-year. While revenue projections for the upcoming quarter dipped 15.8%, earnings estimates have been steady, casting doubt on sustained upward momentum. MASS holds a Zacks Rank #3 (Hold). Meanwhile, industry peer Sight Sciences (SGHT) fell 3.6%, also rated Hold. Investors should watch for shifts in earnings estimate revisions to gauge the durability of 908 Devices' recent strength.
HYMC stock pops in premarket: what’s driving Hycroft Mining as gold tops $4,800
Previous Story

HYMC stock pops in premarket: what’s driving Hycroft Mining as gold tops $4,800

Novavax stock edges up premarket as Pfizer Matrix‑M pact puts $530 million-plus in play
Next Story

Novavax stock edges up premarket as Pfizer Matrix‑M pact puts $530 million-plus in play

Go toTop